2602-14-4 Usage
Chemical structure
A bis-sulfonate ester of 1,3-cyclobutanedimethanol with the sulfonate groups in the cis configuration
Functional groups
Sulfonate ester, cyclobutanediol
Cross-linking agent in polyesters and polyamides
Improves mechanical and thermal properties
Co-monomer in liquid crystal polymers
Enhances polymer properties
Cross-linking agent in ion exchange resins
Enhances ion exchange capacity
Potential application in drug delivery systems
May improve drug release and targeting
Modifier for epoxy resins
Improves performance characteristics
Physical state
Likely a solid or viscous liquid, depending on the temperature and concentration
Solubility
Soluble in organic solvents, such as ethanol, methanol, and acetone
Stability
Stable under normal conditions, but may decompose upon exposure to high temperatures or strong bases
Reactivity
Reacts with nucleophiles, such as amines and alcohols, to form new compounds
Safety
May cause irritation to the eyes, skin, and respiratory system; should be handled with care and proper safety measures
Environmental impact
Potentially harmful to aquatic life and should be disposed of according to local regulations
Check Digit Verification of cas no
The CAS Registry Mumber 2602-14-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,6,0 and 2 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2602-14:
(6*2)+(5*6)+(4*0)+(3*2)+(2*1)+(1*4)=54
54 % 10 = 4
So 2602-14-4 is a valid CAS Registry Number.
2602-14-4Relevant articles and documents
Comparative action of carbocyclic thromboxane A2 stereoisomers on platelets
Caton, Michael P.L.,Stuttle, Keith A.J.,Tuffin, David P.,Ansell, Martin F.
, p. 1099 - 1107 (2000)
Stereospecific requirements for the interaction of the thromboxane A2 carbocyclic mimetic CTA2 1 with the human platelet PGH2/TXA2 receptor have been explored. The two pairs of trans-1,2 and cis-3,4 side chain diastereoisomers were synthesised and evaluated for agonist and antagonist activity in human platelet rich plasma. Interestingly, the natural and unnatural trans diastereoisomers, both possessed potent aggregatory activity and equipotently inhibited platelet responses to subsequent addition of agonists, whereas, the respective unnatural cis isomers proved only weakly active or inert.
